Clincosm LogoSign in Get a demo

Diabetes Mellitus, Type 2

Showing NaN - NaN of 235
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Type 2 Trial in United States (Insulin Icodec)

Recruiting
  • Diabetes Mellitus, Type 2
  • Insulin Icodec
  • Palm Springs, California
  • +8 more
Apr 26, 2023

Obesity, Diabetes, Type 2 Trial in Worldwide (Semaglutide, Placebo)

Recruiting
  • Obesity
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +73 more
Jan 24, 2023

NASH - Nonalcoholic Steatohepatitis, Diabetes, Type 2 Trial in Worldwide (IVA337, Placebo, Empagliflozin)

Recruiting
  • NASH - Nonalcoholic Steatohepatitis
  • Diabetes Mellitus, Type 2
  • Homewood, Alabama
  • +40 more
Jan 23, 2023

Diabetes, Type 2, Cardiovascular Diseases Trial in United States (Intense Education Intervention)

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Cardiovascular Diseases
  • Intense Education Intervention
  • Birmingham, Alabama
  • +43 more
Jan 19, 2023

Diabetes, Type 2 Trial in Worldwide (Semaglutide, Placebo (semaglutide))

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Tuscumbia, Alabama
  • +393 more
Jan 17, 2023

Diabetes, Type 2 Trial in Worldwide (Insulin icodec, Placebo insulin icodec, Insulin degludec)

Completed
  • Diabetes Mellitus, Type 2
  • Insulin icodec
  • +3 more
  • Guntersville, Alabama
  • +91 more
Nov 11, 2022

Diabetes, Type 2 Trial in Worldwide (Insulin icodec, Insulin Glargine 100U/mL, Insulin Degludec)

Completed
  • Diabetes Mellitus, Type 2
  • Insulin icodec
  • +3 more
  • Birmingham, Alabama
  • +178 more
Nov 3, 2022

Diabetes, Type 2, Obesity Trial in Worldwide (Semaglutide, Insuline glargine (reduced), Insuline glargine (titrated))

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Obesity
  • New Port Richey, Florida
  • +28 more
Aug 22, 2022

Diabetes, Type 2 Trial in United States (iRF System Hepatic Denervation)

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • iRF System Hepatic Denervation
  • Birmingham, Alabama
  • +7 more
Aug 10, 2022

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, empagliflozin)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Tuscumbia, Alabama
  • +105 more
Jul 11, 2022

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Lancaster, California
  • +104 more
Jul 11, 2022

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, liraglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +107 more
Jul 11, 2022

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, sitagliptin, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Anniston, Alabama
  • +241 more
Jul 11, 2022

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Little Rock, Arkansas
  • +228 more
Jul 11, 2022

Diabetes, Type 2 Trial in United States (semaglutide, oral glucose-lowering medications (commercially available))

Recruiting
  • Diabetes Mellitus, Type 2
  • semaglutide
  • oral glucose-lowering medications (commercially available)
  • Alhambra, California
  • +23 more
Jul 8, 2022

Diabetes, Type 2 Trial in Worldwide (Insulin icodec, Insulin glargine, Insulin aspart)

Completed
  • Diabetes Mellitus, Type 2
  • Insulin icodec
  • +2 more
  • Concord, California
  • +82 more
Jul 7, 2022

Diabetes, Type 2 Trial in Worldwide (IcoSema, Semaglutide 1 mg)

Recruiting
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +81 more
Jun 28, 2022

Diabetes, Type 2 Trial in Worldwide (Metformin DR, Metformin IR, Metformin DR Placebo)

Recruiting
  • Diabetes Mellitus, Type 2
  • Metformin DR
  • +3 more
  • Glendale, Arizona
  • +86 more
Jun 7, 2022

Heart Failure, Diabetes, Type 2 Trial in Dallas (On-screen electronic alert)

Recruiting
  • Heart Failure
  • Diabetes Mellitus, Type 2
  • On-screen electronic alert
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Apr 12, 2022

Diabetes, Type 2 Trial in Worldwide (Oral semaglutide)

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Oral semaglutide
  • Buena Park, California
  • +177 more
Mar 31, 2022

Diabetes, Type 2 Trial in Worldwide (NNC0480-0389, Semaglutide, Placebo (NNC080-0389))

Recruiting
  • Diabetes Mellitus, Type 2
  • Buena Park, California
  • +95 more
Mar 31, 2022

Diabetes, Type 2 Trial in Worldwide (Insulin degludec, Insulin Icodec)

Completed
  • Diabetes Mellitus, Type 2
  • Insulin degludec
  • Insulin Icodec
  • Buena Park, California
  • +71 more
Mar 29, 2022

Diabetes, Type 2 Trial in Worldwide (IcoSema, Insulin glargine, insulin aspart)

Recruiting
  • Diabetes Mellitus, Type 2
  • La Jolla, California
  • +100 more
Mar 24, 2022

Diabetes, Type 2 Trial in Worldwide (BI 456906, Placebo, Semaglutide)

Completed
  • Diabetes Mellitus, Type 2
  • BI 456906
  • +2 more
  • Huntington Park, California
  • +79 more
Mar 22, 2022

Diabetes, Type 2 Trial in Worldwide (Alogliptin Benzoate, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Alogliptin Benzoate
  • Placebo
  • Little Rock, Arkansas
  • +54 more
Mar 14, 2022